Browsing by Subject "peripheral precocious puberty"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes
    (Elsevier, 2019) Haddad, Nadine G.; Eugster, Erica A.; Pediatrics, School of Medicine
    Peripheral precocious puberty results from peripheral production of sex steroids independent of activation of the hypothalamic-pituitary gonadal axis. It is much less common than central precocious puberty. Causes are variable and can be congenital or acquired. In this review, we will discuss the diagnosis and management of the most common etiologies including congenital adrenal hyperplasia, McCune Albright syndrome, familial male-limited precocious puberty, and adrenal and gonadal tumors.
  • Thumbnail Image
    Item
    Treatment of Peripheral Precocious Puberty
    (Karger, 2016) Schoelwer, Melissa; Eugster, Erica A.; Department of Pediatrics, IU School of Medicine
    There are many etiologies of peripheral precocious puberty (PPP) with diverse manifestations resulting from exposure to androgens, estrogens, or both. The clinical presentation depends on the underlying process and may be acute or gradual. The primary goals of therapy are to halt pubertal development and restore sex steroids to prepubertal values. Attenuation of linear growth velocity and rate of skeletal maturation in order to maximize height potential are additional considerations for many patients. McCune-Albright syndrome (MAS) and familial male-limited precocious puberty (FMPP) represent rare causes of PPP that arise from activating mutations in GNAS1 and the LH receptor gene, respectively. Several different therapeutic approaches have been investigated for both conditions with variable success. Experience to date suggests that the ideal therapy for precocious puberty secondary to MAS in girls remains elusive. In contrast, while the number of treated patients remains small, several successful therapeutic options for FMPP are available.